Gene therapy for diabetes. It sounds like pure science fiction, something that’s decades away. But what if it wasn’t? This concept isn’t just a far-off dream. In fact, AAV gene therapy is already FDA-approved and working in other medical fields. And for diabetes, its approval is right around the corner. We get that this is a confusing, complex topic—even for providers—which is exactly why we recorded this podcast.
Here’s what you’ll learn:
- What AAV gene therapy is (delivering a DNA “blueprint” for a protein like insulin).
- Why this is a “one and done” therapy that could last for years, or even a lifetime.
- How a harmless, engineered virus (called an AAV vector) is used as a “delivery truck.”
- How this new diabetes treatment could work for anyone, even if you’ve had diabetes for 100 years.
- Other FDA approved therapies that use gene therapy technology
- How this approach could allow your own muscle tissue to produce insulin.
- The realistic timeline: Why this is here now, with human trials on the horizon.
